Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

University of Toronto

$86,221.00

SPHEROID-ON-A-CHIP PLATFORM FOR SCREENING TOXICITY OF CHEMICAL AGENTS

FY 2023-24

Summary
Animal models utilized for safety evaluation of chemical agents (CAs) in the chemical, pharmaceutical, and cosmetic industries, as well as in agriculture, are being largely banned by government policies and regulations acts (including Canadian S-214 "The Cruelty Free Cosmetics Act"). Such regulations stimulate the development of reliable and scalable in vitro models for screening CA toxicity. Among them, the utilization of multicellular spheroid/organoid models is highly recommended and favored, however they have at least, one of the following limitations: (i) the insufficient biomimetic nature of spheroid/organoid environment, (ii) the time-consuming model preparation (and thus, long time required for the decision-making step), and (iii) low throughput, that is, the inability to screen simultaneously the toxicity of multiple CAs. The objective of the proposed project is to develop an effective automatic modular spheroid-on-a-chip platform for safety evaluation of a broad range of CAs. Following the fabrication of chemically resistant microfluidic devices, massive arrays of rapidly formed and uniformly sized multilayer skin and cornea spheroids will be grown within 2 days in the biomimetic hydrogel developed in the PI lab. These spheroid arrays will be simultaneously subjected to solutions of up to 200 CAs in a gravity-driven pumpless microfluidic platform. The CA toxicity will be evaluated by determining spheroid metabolic activity and cytokine secretion. The development of this skin and cornea spheroid-on-a-chip platform is a vital step toward safe time-, cost- and labor-effective manufacturing, with a potential application in the areas of agriculture, cosmetics and pharmaceuticals, which are of strategic importance for Canada.
Program
Alliance Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
586435-2023
Name nom
Kumacheva, Eugenia E
Department département
Chemistry (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
86221
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Bioanalytical chemistry
Research subject en
Chimie analytique
Research subject fr
Chimie bioanalytique
Application title
SPHEROID-ON-A-CHIP PLATFORM FOR SCREENING TOXICITY OF CHEMICAL AGENTS
Keyword
bioanalytical assays; bioengineering; eye cells organoids; hydrogels; microfabrication; microfluidics; skin cells organoids; toxic compounds
Application summary
Animal models utilized for safety evaluation of chemical agents (CAs) in the chemical, pharmaceutical, and cosmetic industries, as well as in agriculture, are being largely banned by government policies and regulations acts (including Canadian S-214 "The Cruelty Free Cosmetics Act"). Such regulations stimulate the development of reliable and scalable in vitro models for screening CA toxicity. Among them, the utilization of multicellular spheroid/organoid models is highly recommended and favored, however they have at least, one of the following limitations: (i) the insufficient biomimetic nature of spheroid/organoid environment, (ii) the time-consuming model preparation (and thus, long time required for the decision-making step), and (iii) low throughput, that is, the inability to screen simultaneously the toxicity of multiple CAs. The objective of the proposed project is to develop an effective automatic modular spheroid-on-a-chip platform for safety evaluation of a broad range of CAs. Following the fabrication of chemically resistant microfluidic devices, massive arrays of rapidly formed and uniformly sized multilayer skin and cornea spheroids will be grown within 2 days in the biomimetic hydrogel developed in the PI lab. These spheroid arrays will be simultaneously subjected to solutions of up to 200 CAs in a gravity-driven pumpless microfluidic platform. The CA toxicity will be evaluated by determining spheroid metabolic activity and cytokine secretion. The development of this skin and cornea spheroid-on-a-chip platform is a vital step toward safe time-, cost- and labor-effective manufacturing, with a potential application in the areas of agriculture, cosmetics and pharmaceuticals, which are of strategic importance for Canada.